Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:16 am
Author: Getaka|Social: XLinkedIn

MK Proteins Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹3.83Overvalued by 12.36%vs CMP ₹4.37

P/E (19.3) × ROE (12.4%) × BV (₹1.96) × DY (2.00%)

₹3.22Overvalued by 26.32%vs CMP ₹4.37
MoS: -35.7% (Negative)Confidence: 63/100 (Moderate)Models: 1 Under, 8 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹3.6722%Over (-16%)
Graham NumberEarnings₹3.1116%Over (-28.8%)
Earnings PowerEarnings₹2.2813%Over (-47.8%)
DCFCash Flow₹2.0913%Over (-52.2%)
Net Asset ValueAssets₹1.977%Over (-54.9%)
EV/EBITDAEnterprise₹2.729%Over (-37.8%)
Earnings YieldEarnings₹2.207%Over (-49.7%)
ROCE CapitalReturns₹7.519%Under (+71.9%)
Revenue MultipleRevenue₹3.575%Over (-18.3%)
Consensus (9 models)₹3.22100%Overvalued

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -4.0%

*Investments are subject to market risks

Investment Snapshot

61
MK Proteins Ltd scores 61/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health76/100 · Strong
ROCE 12.9% GoodROE 12.4% GoodD/E 0.83 ModerateInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money50/100 · Moderate
FII holding stable No changePromoter holding at 74.8% Stable
Earnings Quality50/100 · Moderate
OPM stable around 6% Steady
Quarterly Momentum60/100 · Moderate
Revenue (4Q): +72% YoY AcceleratingProfit (4Q): -26% YoY Declining
Industry Rank60/100 · Moderate
P/E 19.3 vs industry 263.2 Cheaper than peersROCE 12.9% vs industry 14.3% Average3Y sales CAGR: 2% Slow

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:16 am

Market Cap 164 Cr.
Current Price 4.37
Intrinsic Value₹3.22
High / Low 9.78/3.56
Stock P/E19.3
Book Value 1.96
Dividend Yield0.00 %
ROCE12.9 %
ROE12.4 %
Face Value 1.00
PEG Ratio-4.81

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for MK Proteins Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
MK Proteins Ltd 164 Cr. 4.37 9.78/3.5619.3 1.960.00 %12.9 %12.4 % 1.00
Ajanta Soya Ltd 154 Cr. 19.2 51.9/16.010.6 20.60.00 %26.8 %18.1 % 2.00
Ruchi Infrastructure Ltd 117 Cr. 4.95 10.9/4.0511.1 8.840.00 %2.89 %0.85 % 1.00
Gokul Refoils and Solvent Ltd 374 Cr. 37.8 54.0/31.019.4 35.50.00 %8.40 %4.12 % 2.00
Modi Naturals Ltd 403 Cr. 303 610/25210.4 1070.00 %18.7 %29.2 % 10.0
Industry Average11,412.83 Cr130.95263.2137.260.19%14.31%12.90%4.29

All Competitor Stocks of MK Proteins Ltd

Quarterly Result

MetricMar 2017Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 53.5976.2013.6468.8686.8757.3333.6939.48137.20114.9532.4389.56
Expenses 51.6972.2113.0065.3078.4453.5931.4637.69132.55109.4431.3987.19
Operating Profit 1.903.990.643.568.433.742.231.794.655.511.042.37
OPM % 3.55%5.24%4.69%5.17%9.70%6.52%6.62%4.53%3.39%4.79%3.21%2.65%
Other Income 0.01-0.000.030.010.41-0.000.210.250.02-0.000.120.02
Interest 0.690.520.040.110.400.330.030.070.670.700.060.30
Depreciation 0.300.120.120.120.180.070.070.110.090.100.110.12
Profit before tax 0.923.350.513.348.263.342.341.863.914.710.991.97
Tax % 36.96%25.67%21.57%25.75%29.42%25.45%25.21%25.81%28.64%25.27%25.25%26.90%
Net Profit 0.572.490.412.485.832.481.741.382.803.510.751.43
EPS in Rs 0.020.070.010.070.160.070.050.040.070.090.020.04

Last Updated: March 4, 2026, 12:46 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 24, 2026, 9:46 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 122123145165172157194311256315245268374
Expenses 119119141160166152189295240298229255361
Operating Profit 3445655161617171314
OPM % 2%3%3%3%3%3%2%5%6%5%7%5%4%
Other Income 0000000001000
Interest 2222222112112
Depreciation 0111111111100
Profit before tax 1112222141415151112
Tax % 33%32%31%35%35%28%26%27%27%27%28%27%
Net Profit 01111221010111188
EPS in Rs 0.821.401.200.040.040.040.050.280.270.290.300.220.22
Dividend Payout % 0%0%0%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)0.00%0.00%0.00%100.00%0.00%400.00%0.00%10.00%0.00%-27.27%
Change in YoY Net Profit Growth (%)0.00%0.00%0.00%100.00%-100.00%400.00%-400.00%10.00%-10.00%-27.27%

MK Proteins Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:8%
5 Years:7%
3 Years:2%
TTM:44%
Compounded Profit Growth
10 Years:25%
5 Years:35%
3 Years:-7%
TTM:-16%
Stock Price CAGR
10 Years:%
5 Years:49%
3 Years:39%
1 Year:-36%
Return on Equity
10 Years:21%
5 Years:23%
3 Years:18%
Last Year:12%

Last Updated: September 5, 2025, 10:00 am

Balance Sheet

Last Updated: December 10, 2025, 3:01 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 0.680.680.6834444413383838
Reserves 1232111315253537243236
Borrowings 2820263133263125374620392
Other Liabilities 21310128471310815224
Total Liabilities 3235394756475767861039613180
Fixed Assets 3677643233343
CWIP 3000000000677
Investments 0000000000004
Other Assets 2629324050435365831008812066
Total Assets 3235394756475767861039613180

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + -511-4-4-126-46-10-632-16
Cash from Investing Activity + -3-0-2-1-000-0-20-6-1
Cash from Financing Activity + 8-106512-74-5126-2718
Net Cash Flow -0-00-00-00-0000-0
Free Cash Flow -810-6-5-126-45-12-627-18
CFO/OP -179%267%-92%-65%-202%150%-77%44%-39%-6%216%-95%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-25.00-16.00-22.00-26.00-27.00-21.00-26.00-9.00-21.00-29.00-3.00-26.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 1916271039251824421952
Inventory Days 62705783697579488091134170
Days Payable 6392223126810861929
Cash Conversion Cycle 7547627097948962114104120142
Working Capital Days 69119204432363655577781
ROCE %10%14%13%12%11%8%8%29%23%20%19%13%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 74.82%74.82%74.82%74.82%74.83%74.83%74.83%74.82%74.82%74.82%74.82%74.82%
FIIs 0.00%0.00%0.00%0.00%0.02%0.02%0.00%0.00%0.00%0.00%0.00%0.00%
Public 25.18%25.17%25.17%25.18%25.16%25.15%25.17%25.18%25.17%25.18%25.17%25.18%
No. of Shareholders 1503441,4546,58737,28936,01843,39555,88267,75471,65672,29471,538

Shareholding Pattern Chart

No. of Shareholders

MK Proteins Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.0010.0010.0010.00
Basic EPS (Rs.) 0.220.308.5124.4224.91
Diluted EPS (Rs.) 0.220.308.5124.4224.91
Cash EPS (Rs.) 0.230.319.1126.6127.09
Book Value[Excl.RevalReserv]/Share (Rs.) 1.851.6340.1894.9570.34
Book Value[Incl.RevalReserv]/Share (Rs.) 1.851.6340.1894.9570.34
Revenue From Operations / Share (Rs.) 7.136.54251.64613.52745.89
PBDIT / Share (Rs.) 0.340.4513.6637.8538.31
PBIT / Share (Rs.) 0.330.4413.0635.6636.13
PBT / Share (Rs.) 0.300.4111.6733.6734.34
Net Profit / Share (Rs.) 0.220.298.5124.4224.91
PBDIT Margin (%) 4.826.945.426.165.13
PBIT Margin (%) 4.696.735.185.814.84
PBT Margin (%) 4.276.294.635.484.60
Net Profit Margin (%) 3.134.563.383.983.33
Return on Networth / Equity (%) 12.0818.3521.1725.7135.41
Return on Capital Employeed (%) 17.5426.5430.8735.1344.53
Return On Assets (%) 6.4311.6410.1411.8215.42
Long Term Debt / Equity (X) 0.010.000.050.060.15
Total Debt / Equity (X) 0.540.310.880.920.83
Asset Turnover Ratio (%) 2.362.443.303.335.02
Current Ratio (X) 2.012.531.961.881.92
Quick Ratio (X) 0.120.190.580.740.79
Inventory Turnover Ratio (X) 2.812.734.234.495.77
Interest Coverage Ratio (X) 11.6816.029.8618.9621.31
Interest Coverage Ratio (Post Tax) (X) 8.6011.537.1413.2314.86
Enterprise Value (Cr.) 264.44389.87957.87116.6557.72
EV / Net Operating Revenue (X) 0.981.593.040.450.18
EV / EBITDA (X) 20.4922.8556.037.393.61
MarketCap / Net Operating Revenue (X) 0.841.512.900.310.10
Price / BV (X) 3.266.0718.172.021.13
Price / Net Operating Revenue (X) 0.841.512.900.310.10
EarningsYield 0.030.030.010.120.31

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

M K Proteins Ltd. is a Public Limited Listed company incorporated on 15/06/2012 and has its registered office in the State of Haryana, India. Company's Corporate Identification Number(CIN) is L15500HR2012PLC046239 and registration number is 046239. Currently company belongs to the Industry of Edible Oils & Solvent Extraction. Company's Total Operating Revenue is Rs. 267.71 Cr. and Equity Capital is Rs. 37.54 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Edible Oils & Solvent ExtractionNaraingarh Road, Village Garnala, Ambala District Haryana 134003Contact not found
Management
NamePosition Held
Mr. Parvind KumarChairman
Mr. Parmod KumarManaging Director
Mr. Vinod KumarWhole Time Director
Ms. Laxmi MandalIndependent Director
Mr. Tej Mohan SinghIndependent Director
Mrs. Shipra JainIndependent Director
Mr. Raj KumarNon Executive Director

FAQ

What is the intrinsic value of MK Proteins Ltd and is it undervalued?

As of 14 April 2026, MK Proteins Ltd's intrinsic value is ₹3.22, which is 26.32% lower than the current market price of ₹4.37, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (12.4 %), book value (₹1.96), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of MK Proteins Ltd?

MK Proteins Ltd is trading at ₹4.37 as of 14 April 2026, with a FY2026-2027 high of ₹9.78 and low of ₹3.56. The stock is currently near its 52-week low. Market cap stands at ₹164 Cr..

How does MK Proteins Ltd's P/E ratio compare to its industry?

MK Proteins Ltd has a P/E ratio of 19.3, which is below the industry average of 263.21. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is MK Proteins Ltd financially healthy?

Key indicators for MK Proteins Ltd: ROCE of 12.9 % is moderate. Dividend yield is 0.00 %.

Is MK Proteins Ltd profitable and how is the profit trend?

MK Proteins Ltd reported a net profit of ₹8 Cr in Mar 2025 on revenue of ₹268 Cr. Compared to ₹10 Cr in Mar 2022, the net profit shows a declining trend.

Does MK Proteins Ltd pay dividends?

MK Proteins Ltd has a dividend yield of 0.00 % at the current price of ₹4.37. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in MK Proteins Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports